Life Sciences

Acton-based Bluejay Diagnostics, Inc. has partnered with Tokyo-based Toray Industries to develop a minimally-invasive, point-of-care test for COVID-19 patients to assess progression of the disease.

A Massachusetts state board has approved tax breaks for business expansions in Leominster, Marlborough and Webster, as well as a new vacant-storefront incentive program for Westborough.

Marlborough’s WaterSep BioSeparations has been purchased for $27 million by France-based Sartorius Stedim Biotech.

A gene therapy startup company at Worcester's Massachusetts Biomedical Initiatives incubator has raised $13 million in new funding to be used to establish a manufacturing facility in Lexington.

The Beverly Hills-based Schall Law Firm on Monday announced it is filing a class action lawsuit against Marlborough medical device manufacturer Boston Scientific, alleging potential Securities Exchange Act violations, according to a press release from the lawyers.

Milford life sciences company Waters Corp. has reported Sherry Buck will step down as chief financial officer at the end of December.

Marlborough medical device manufacturer Boston Scientific Corp. has entered into an agreement to sell its BTG Specialty Pharmaceuticals business for $800 million in cash.

Marlborough medical device company Hologic has won regulatory approval for a new device using artificial intelligence to detect subtle potential breast cancers.

King Street Properties, a Boston development firm that bought three Devens sites this year, is planning a $500-million life sciences complex in a major boon to the former military base.

California’s Revance Therapeutics has secured a tax increment financing agreement with Marlborough to cover a planned $115-million new construction with the company committing to the creation of 76 jobs.